menu
    • menu

    Company profile for Citius Pharmaceuticals

    NEW Drugs in Dev: 8
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of important new drug products for growing markets. Citius is currently advancing three proprietary product candidates: Mino-Lok®, CITI-002 (halobetasol-lidocaine formulation) and CITI-101 (Mino-Wrap). Citius believes the markets for its products are large and underserved by the current standard of ca...
    Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of important new drug products for growing markets. Citius is currently advancing three proprietary product candidates: Mino-Lok®, CITI-002 (halobetasol-lidocaine formulation) and CITI-101 (Mino-Wrap). Citius believes the markets for its products are large and underserved by the current standard of care. Citius is committed to developing therapies for unmet medical needs with cost-effective products in high growth categories with low developmental risk.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Citius PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11 Commerce Dr, 1st Floor, Cranford, New Jersey 07016
    Telephone
    Telephone
    908.967.6677
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.citiuspharma.com/home/default.aspx
    Linkedin
    Linkedin
    https://www.linkedin.com/company/citius-pharmaceuticals-inc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/CitiusPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Citius Oncology Ship 1st International Order of LYMPHIR to Europe
    Citius Oncology Ship 1st International Order of LYMPHIR to Europe

    29 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/citius-oncology-ships-first-international-order-of-lymphir-to-europe-302757013.html

    PR NEWSWIRE
    29 Apr 2026
    Share Share
    Citius Pharma Launches $5M Direct Offering Under Nasdaq Rules
    Citius Pharma Launches $5M Direct Offering Under Nasdaq Rules

    24 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/citius-pharmaceuticals-announces-a-registered-direct-offering-of-5-million-priced-at-the-market-under-nasdaq-rules-302752444.html

    PR NEWSWIRE
    24 Apr 2026
    Share Share
    Citius Oncology Updates on LYMPHIR™ Launch and Pipeline Expansion
    Citius Oncology Updates on LYMPHIR™ Launch and Pipeline Expansion

    31 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/citius-oncology-provides-commercial-update-on-lymphir-launch-highlighting-early-adoption-and-expanding-clinical-development-302729879.html

    PR NEWSWIRE
    31 Mar 2026
    Share Share
    Citius Pharma Secures $3.8M From Nj Economic Development Program
    Citius Pharma Secures $3.8M From Nj Economic Development Program

    24 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/citius-pharmaceuticals-inc-secures-3-8-million-through-new-jersey-economic-development-program-302695166.html

    PR NEWSWIRE
    24 Feb 2026
    Share Share
    Citius Pharma Reports First Revenue After LYMPHIR Launch
    Citius Pharma Reports First Revenue After LYMPHIR Launch

    13 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/citius-pharmaceuticals-inc-announces-first-reported-revenue-following-successful-launch-of-lymphir-302687092.html

    PR NEWSWIRE
    13 Feb 2026
    Share Share
    Citius Pharma Reveals Fy2025 Financials And Business Update
    Citius Pharma Reveals Fy2025 Financials And Business Update

    24 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/citius-pharmaceuticals-inc-reports-fiscal-year-2025-financial-results-and-provides-business-update-302648899.html

    PR NEWSWIRE
    24 Dec 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search